NO20084711L - Nytt synergistisk, farmasoytisk preparat - Google Patents

Nytt synergistisk, farmasoytisk preparat

Info

Publication number
NO20084711L
NO20084711L NO20084711A NO20084711A NO20084711L NO 20084711 L NO20084711 L NO 20084711L NO 20084711 A NO20084711 A NO 20084711A NO 20084711 A NO20084711 A NO 20084711A NO 20084711 L NO20084711 L NO 20084711L
Authority
NO
Norway
Prior art keywords
pharmaceutical preparation
new synergistic
synergistic
new
bacterium
Prior art date
Application number
NO20084711A
Other languages
English (en)
Inventor
Meenakshi Balganesh
Santosh Nandan
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20084711L publication Critical patent/NO20084711L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Det beskrives et terapeutisk middel for administrering til en bakterie eller dennes omgivelser, der middelet omfatter synergistisk effektive mengder av (i) en RNApolymeraseinhibitor og (ii) en ALS-enzyminhibitor.
NO20084711A 2006-05-11 2008-11-07 Nytt synergistisk, farmasoytisk preparat NO20084711L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN836CH2006 2006-05-11
PCT/GB2007/001719 WO2007132189A1 (en) 2006-05-11 2007-05-09 New synergistic pharmaceutical composition

Publications (1)

Publication Number Publication Date
NO20084711L true NO20084711L (no) 2008-11-07

Family

ID=38236511

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084711A NO20084711L (no) 2006-05-11 2008-11-07 Nytt synergistisk, farmasoytisk preparat

Country Status (12)

Country Link
US (2) US20090181980A1 (no)
EP (1) EP2019855A1 (no)
JP (1) JP2009536634A (no)
KR (1) KR20090007583A (no)
CN (1) CN101443443A (no)
AU (1) AU2007251373A1 (no)
BR (1) BRPI0710977A2 (no)
CA (1) CA2650805A1 (no)
IL (1) IL194844A0 (no)
MX (1) MX2008014373A (no)
NO (1) NO20084711L (no)
WO (1) WO2007132189A1 (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112190589A (zh) * 2020-11-17 2021-01-08 首都医科大学附属北京胸科医院 非达霉素在制备抑制鸟分枝杆菌活性的产品中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998420A (en) * 1996-04-08 1999-12-07 University Of Medicine & Dentistry Of New Jersey Method for treating Mycobacterium tuberculosis
DE10216719B4 (de) * 2002-04-10 2007-09-20 Helmholtz-Zentrum Für Umweltforschung Gmbh - Ufz N-(3-Rifamycinyl)carbamate, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Behandlung und Verhütung von Tuberkulose
PT102807A (pt) * 2002-07-09 2004-01-30 Inst Nac De Engenharia E Tecno Derivados n-substituidos de rifabutina uteis como agentes antimicrobianos, processo para a sua preparacao e sua utilizacao como medicamentos

Also Published As

Publication number Publication date
EP2019855A1 (en) 2009-02-04
KR20090007583A (ko) 2009-01-19
CN101443443A (zh) 2009-05-27
AU2007251373A1 (en) 2007-11-22
JP2009536634A (ja) 2009-10-15
US20090181980A1 (en) 2009-07-16
WO2007132189A1 (en) 2007-11-22
BRPI0710977A2 (pt) 2011-05-31
CA2650805A1 (en) 2007-11-22
US20070275982A1 (en) 2007-11-29
MX2008014373A (es) 2008-11-19
IL194844A0 (en) 2009-08-03

Similar Documents

Publication Publication Date Title
WO2007103719A3 (en) MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
EA200870216A1 (ru) Амидо соединения и их применение в качестве лекарственных средств
WO2007084314A3 (en) MODULATORS OF 11-ß HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
NO20085243L (no) Farmasoytisk sammensetning til behandling av virusinfeksjoner og/eller tumorsykdommer gjennom inhibering av proteinfolding og Proteinnedbryting
NO20081838L (no) 5-lipoksygenaseaktiverende protein-(FLAP)-inhibitorer
NO20090469L (no) Substituerte piperidiner som oker P53-aktiviteten, og anvendelse derav
AU2011201462B2 (en) Method of Administering Pirfenidone Therapy
NO20092569L (no) Inhibitorer av Akt-aktivitet
CL2012001043A1 (es) Compuestos derivados de hexahidroindenopiridina y/o octahidrobenzoquinolina, inhibidores de 11ß-hidroxiesteroide deshidrogenasa 1 (hsd 1); composiciones farmaceuticas que comprenden a los compuestos; y uso de los compuestos para la preparacion de medicamentos para el tratamiento de trastornos metabolicos.
EA200870019A1 (ru) Лактамовые соединения и способы их применения
WO2008033562A3 (en) Kinase inhibitor compounds
CL2009000316A1 (es) Compuestos derivados de urea de benzomorfanos y sus sales, inhibidores de la enzima 11-beta-hidroxiesteroide deshidrogenasa; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento o prevencion de trastornos metabolicos.
MY146969A (en) Dpp iv inhibitor formulations
CO6321290A2 (es) Nuevos inhibidores macrociclicos basados en pirrolidinilo de la replicacion de virus de la hepatitis c
MY142589A (en) Benzimidazole derivatives : preparation and pharmaceutical applications
BR112012027034A2 (pt) inibidores da arginase e suas aplicações terapêuticas
EP2349279A4 (en) ALDEHYDE DEHYDROGENASE MODULATORS AND METHOD OF USE THEREOF
ATE511514T1 (de) Phosphadiazin-hcv-polymerase-hemmer vom typ iv
BRPI0508254A (pt) métodos e composições para o tratamento ou prevenção de distúrbios psiquiátricos com inibidores de cox-2 sozinhos e em combinação com agentes antidepressivos
CL2008001782A1 (es) Uso de una composicion que comprende un compuesto derivado de heterociclo para tratar o prevenir la perdida de flujo intestinal; composicion que comprende dicho compusto; y kit que comprende la composicion.
TW200745047A (en) Heterocyclic compounds
ATE489371T1 (de) Benzamidglucokinaseaktivatoren
UY30918A1 (es) Moduladores de lta4h y sus usos
NO20085414L (no) Farmasoytiske preparater for vedvarende frigivelse av fenylefrin
WO2008064345A3 (en) Microorganism killing compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application